Metabolic dysfunction-associated steatohepatitis+1
Not recruitingStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
- Disease:Metabolic dysfunction-associated steatohepatitisNon-alcoholic steatohepatitis
- Substances:Semaglutide
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Semaglutide
- Sponsor:Novo Nordisk A/S








